/

Empresas

Al

No verificado

Alloy Therapeutics

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMercado laboralSalud

5 Comunicados de prensa

Ver todos los comunicados de prensa

13/01/2026

Oncología

Salud

Técnica

Farmacéutica

Biotecnología

Mercado laboral

Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers

Fuente

Alloy Therapeutics

Editor

1.00

0

06/01/2026

Mercado laboral

Software

Biotecnología

Farmacéutica

Salud

Técnica

Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines

Fuente

Alloy Therapeutics

Editor

1.00

0

11/02/2025

Ciencia

Biotecnología

Sanidad

Salud

Farmacéutica

Oncología

Mercado laboral

Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform

Fuente

Alloy Therapeutics

Editor

1.00

0

09/01/2025

Industria

Biotecnología

Salud

Ciencia

Farmacéutica

Alloy Therapeutics Announces New Licensing Model for ATX-Gx™ Antibody Discovery Platform and Launches mAbForge™ High-Throughput Screening Service

Fuente

Alloy Therapeutics

Editor

1.00

0

30/10/2024

Mercado laboral

Salud

Higiene alimentaria

Biotecnología

Ciencia

Farmacéutica

Alloy Therapeutics Announces Institutional License Agreement with Scripps Research for its ATX-Gx™ Platform for Fully Human Antibody Discovery

Fuente

Alloy Therapeutics

Editor

1.00

0

Seguidores

0

Compatibilidad

0